HealthCommentary

Exploring Human Potential

Mylan EpiPen? What About Medicare Part D?

Mike Magee Pediatric drug prices have led the news recently with the fantastic and purposeful price escalation of Mylan’s EpiPen. With all that going on, it would have been easy to miss the analysis of the complete Medicare Part D year over year costs (2014 vs. 2013) that were recently released. 70% of Medicare patients […]

Show Buttons
Hide Buttons